The FDAs enforcement of its compounding policies will likely result in increased reliance on FDA-approved medications for treating diabetes and obesity
2022;7: e154573
If you found this article even a little helpful, I would be happy if you could support me with a 'Like ()'
1 Endocrinology and Metabolism, Charite Universitaetsmedizin Berlin, Berlin, Germany, 2 German Center for Cardiovascular Research, Charite Universitaetsmedizin Berlin, Berlin, Germany, 3 German Center for Rheumatism Research, Charite Universitaetsmedizin Berlin, Berlin, Germany, 45 University of Pisa, Pisa, Italy, 6 Institute of Neuroscience, National Research Council (CNR) of Padova, Padova, Italy
Additionally, obesity-related pro-inflammatory molecules released by adipose tissue exacerbate inflammation, ultimately contributing to endothelial dysfunction, plaque formation, and the progression of atherosclerosis (118, 119)